rs755459875
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001173990.3(TMEM216):c.398T>G(p.Leu133*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000013 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001173990.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM216 | NM_001173990.3 | c.398T>G | p.Leu133* | stop_gained | Exon 4 of 5 | ENST00000515837.7 | NP_001167461.1 | |
TMEM216 | NM_001173991.3 | c.398T>G | p.Leu133* | stop_gained | Exon 4 of 5 | NP_001167462.1 | ||
TMEM216 | NM_016499.6 | c.215T>G | p.Leu72* | stop_gained | Exon 4 of 5 | NP_057583.2 | ||
TMEM216 | NM_001330285.2 | c.215T>G | p.Leu72* | stop_gained | Exon 4 of 5 | NP_001317214.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 249212Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135212
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461628Hom.: 0 Cov.: 35 AF XY: 0.0000138 AC XY: 10AN XY: 727114
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
Joubert syndrome 2 Pathogenic:2
Variant summary: TMEM216 c.398T>G (p.Leu133X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 8e-06 in 249212 control chromosomes (gnomAD). c.398T>G has been reported in the literature as a compound heterozygous genotype in at least one individual affected with Joubert Syndrome 2 (example, Valente_2010, Bachmann-Gagescu_2015). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26092869, 20512146). ClinVar contains an entry for this variant (Variation ID: 217704). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
Joubert syndrome 2;C1864148:Meckel syndrome, type 2 Pathogenic:1
- -
TMEM216-related disorder Pathogenic:1
The TMEM216 c.398T>G variant is predicted to result in premature protein termination (p.Leu133*). This variant has been identified in two presumably unrelated individuals with Joubert syndrome and related disorders (Valente et al. 2010. PubMed ID: 20512146; Bachmann-Gagescu et al. 2015. PubMed ID: 26092869). This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in TMEM216 are expected to be pathogenic. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
The L133X variant in the TMEM216 gene has been reported previously, along with a TMEM216 missense variant, in individuals with clinical findings of Joubert syndrome (Valente et al., 2010; Bachmann-Gagescu et al., 2015). This variant is predicted to cause loss of normal protein function through protein truncation. The L133X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret L133X as a likely pathogenic variant. -
Familial aplasia of the vermis Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Leu133*) in the TMEM216 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 13 amino acid(s) of the TMEM216 protein. This variant is present in population databases (rs755459875, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with Joubert syndrome (PMID: 20512146, 26092869). ClinVar contains an entry for this variant (Variation ID: 217704). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at